床旁高敏肌钙蛋白I毛细血管血分析用于急性冠脉综合征诊断的验证
该研究纳入152例因急性胸痛就诊于心脏急诊科的患者,比较毛细血管血、静脉全血与血浆在Atellica VTLi床旁免疫分析仪上的高敏肌钙蛋白结果,并以中心实验室血浆免疫分析作为对照。结果显示静脉全血与血浆间无显著差异,毛细血管血与静脉血间存在7.1%的恒定偏差并已设校正因子,毛细血管床旁结果与中心实验室血浆结果无临床相关差异。
要点
- 静脉全血与血浆在Atellica VTLi床旁分析仪上结果无显著差异。
- 毛细血管血与静脉血间存在7.1%恒定偏差,已实施校正因子。
- 毛细血管床旁结果与中心实验室血浆结果无临床相关差异。
核心结论
- Atellica VTLi床旁高敏肌钙蛋白分析仪在包括毛细血管血在内的各样本类型间结果等效。
- 毛细血管床旁与中心实验室结果间未观察到临床相关的不一致。
研究设计与样本
- 研究纳入152例因急性胸痛入住心脏急诊科的患者。
- 比较毛细血管血与经静脉穿刺获得的静脉全血及血浆样本。
- 所有样本均用Atellica VTLi床旁免疫分析仪分析,血浆另用中心实验室免疫分析仪分析。
主要发现
- Atellica VTLi分析仪检测的静脉全血与血浆之间无显著差异。
- 毛细血管血与静脉血之间显示7.1%的恒定偏差,已实施校正因子。
- 毛细血管床旁结果与标准免疫分析仪检测血浆相比无临床相关差异。
临床怎么用
- 该床旁高敏肌钙蛋白分析可用于急诊胸痛患者的快速分诊与处置决策。
- 经进一步研究后,有望在救护车或全科医生诊室开展高敏肌钙蛋白快速检测,无需急性胸痛患者住院。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Patients with acute coronary syndrome (ACS) should be referred promptly to the hospital to reduce mortality and morbidity. Differentiating between low-risk and high-risk patients remains a diagnostic challenge. Point-of-care testing can contribute to earlier disposition decisions for patients excluded from ACS. This study describes the validation of the Atellica® VTLi. Patient-side Immunoassay Analyzer for high-sensitivity troponin point-of-care (POC) analysis. (The Atellica VTLi is not available for sale in the USA. The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed). METHODS: A total of 152 patients with acute chest pain admitted at the cardiac emergency department (ED) were included in the study. Capillary blood was compared with a whole blood and plasma sample obtained by venipuncture. All samples were analyzed using the Atellica VTLi Patient-side Immunoassay Analyzer; in addition, plasma was analyzed by a central lab immunoassay analyzer. RESULTS: No significant difference was observed between venous whole blood vs. plasma analyzed by the Atellica VTLi Patient-side Immunoassay Analyzer. The difference between capillary blood and venous blood showed a constant bias of 7.1%, for which a correction factor has been implemented. No clinically relevant differences were observed for the capillary POC results compared to plasma analyzed with a standard immunoassay analyzer. CONCLUSIONS: The Atellica VTLi Patient-side Immunoassay Analyzer for high-sensitivity troponin analysis shows equivalent results for all sample types, including capillary blood. No clinically relevant discordances were observed between capillary POC and central laboratory results. With additional studies, this could pave the way towards rapid testing of high-sensitivity troponin in the ambulance or the general practitioner's office without the need for hospitalization of patients with acute chest pain.
引用
- Bruinen AL, Frenk LDS, de Theije F, et al. Point-of-care high-sensitivity troponin-I analysis in capillary blood for acute coronary syndrome diagnostics. Clin Chem Lab Med. 2022. PMID: 35858956. doi:10.1515/cclm-2022-0268
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。